HARVARD BIOSCIENCE INC (NASDAQ:HBIO) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
HARVARD BIOSCIENCE INC's stock currently trades at $0.54 with a market capitalization of $33.5M. The Healthcare company's stock moved following the disclosure.


